APA (7th ed.) Citation

Giuliani, A., Ramini, D., Sbriscia, M., Crocco, P., Tiano, L., Rippo, M. R., . . . Sabbatinelli, J. (2024). Syndecan 4 is a marker of endothelial inflammation in pathological aging and predicts long-term cardiovascular outcomes in type 2 diabetes. Diabetology & Metabolic Syndrome, 16(1), 1. https://doi.org/10.1186/s13098-024-01431-8

Chicago Style (17th ed.) Citation

Giuliani, Angelica, et al. "Syndecan 4 Is a Marker of Endothelial Inflammation in Pathological Aging and Predicts Long-term Cardiovascular Outcomes in Type 2 Diabetes." Diabetology & Metabolic Syndrome 16, no. 1 (2024): 1. https://doi.org/10.1186/s13098-024-01431-8.

MLA (9th ed.) Citation

Giuliani, Angelica, et al. "Syndecan 4 Is a Marker of Endothelial Inflammation in Pathological Aging and Predicts Long-term Cardiovascular Outcomes in Type 2 Diabetes." Diabetology & Metabolic Syndrome, vol. 16, no. 1, 2024, p. 1, https://doi.org/10.1186/s13098-024-01431-8.